P-1013

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1993-1995
012319931995

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1995
1995
4,6-Benzylidene-D-glucose (BG), is a known antitumour substance with low clinical toxicity. In order to increase the antitumour… (More)
Is this relevant?
1995
1995
4,6-Benzylidene-d1-D-glucose, P-1013, a deuterated benzaldehyde derivative which acts as a reversible protein synthesis inhibitor… (More)
Is this relevant?
1995
1995
The benzaldehyde derivative 4,6-benzylidene-d-glucose (BG) induces an inhibition of protein synthesis at otherwise non-toxic… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • table 2
Is this relevant?
1993
1993
In vivo pharmacokinetics of the antitumour agent 4,6-benzylidene-D-glucose (BG) and a deuterated analog 4,6-benzylidene-d1-D… (More)
Is this relevant?